Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

ADHD drug prescriptions surge 38% in 2 years

Prescriptions for methylphenidate, an attention-deficit hyperactivity disorder (ADHD) treatment widely known as "study drug" among students in Korea, have surged nearly 38 percent over the past two years in the country and are especially high among people aged 19 and under, data showed Sunday. According to the Ministry of Food and Drug Safety and the Korea Institute of Drug Safety and Risk…

ADHD drug prescriptions surge 38% in 2 years

Prescriptions for methylphenidate, an ADHD treatment often referred to as a "study drug" by students in Korea, have increased by nearly 38% over the past two years, according to recent data. This surge predominantly affects individuals aged 19 and younger. As of the first half of this year, 58.05 million methylphenidate tablets were prescribed, marking a 12.1% increase from the same period last year.

This represents a 37.8% rise compared to the first half of 2024, when 42.13 million tablets were prescribed. Despite being a controlled medical substance requiring a doctor's prescription, the data reveals an alarming trend among younger age groups. Half of all prescriptions were issued to individuals aged 19 and under, with 28.81 million tablets going to this demographic alone.

Males accounted for 20.9 million of the tablets, significantly higher than the 7.91 million prescribed to females.

Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Other reports of this story

Every outlet that reported this, and when →

Read the original at koreatimes.co.kr →

More in Health & Medicine

More from Sunday 4 October →